In line with these observations, we showed that inhibition of PI3-K-Akt signaling, either by LY294002 or Akt1/2 siRNA markedly downregulated the motility of PANC-1 and Colo-699 carcinoma cells (Fig. 2). Here, AKT1 is linked to carcinoma.